Browse Drug Recalls

412 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 412 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 412 FDA drug recalls.

Clear
DateProductReasonClassFirm
Sep 13, 2016 buPROPion Hydrochloride Extended-release Tablets, USP (SR), 150 mg, Twice-A-D... Failed Dissolution Specifications Class III Sun Pharmaceutical Industries, Inc.
Aug 29, 2016 ZENATANE (isotretinoin capsules USP) 20 mg, 30 capsules per prescription pack... Failed Dissolution Specifications Class III Dr. Reddy's Laboratories, Inc.
Aug 23, 2016 Selegiline HCL Tablets USP 5mg, 60- count bottles, Rx only, Manufactured by: ... Stason Pharmaceuticals is recalling Selegiline HCl tablets, USP 5mg 60 count bottle due to an out... Class III Stason Pharmaceuticals, Inc.
Aug 4, 2016 buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count ... Failed dissolution specifications - the out of specification result for dissolution was identifie... Class III Amerisource Health Services
Aug 3, 2016 BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, ... Failed Dissolution Specifications: Product did not meet dissolution specification at an intermedi... Class III Zydus Pharmaceuticals USA Inc
Aug 3, 2016 Venlafaxine Hydrochloride Extended-Release Capsules, 75 mg, 90 capsules per ... Failed Dissolution Specifications: Out-of-specification results in retained sample. Class II Golden State Medical Supply Inc.
Aug 3, 2016 Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules p... Failed Dissolution Specifications: Out-of-specification results in retained sample. Class II Golden State Medical Supply Inc.
Jul 19, 2016 Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68... Failed Dissolution Specifications: out of specification dissolution results in retained samples Class II Zydus Pharmaceuticals USA Inc
Jul 19, 2016 Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 6... Failed Dissolution Specifications: out of specification dissolution results in retained samples Class II Zydus Pharmaceuticals USA Inc
Jul 11, 2016 Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg, 90- count bottles... Failed Dissolution Specifications Class II Actavis Inc
Jun 30, 2016 Glipizide 2.5 mg Extended-release tablets, 30-count bottle, Rx Only, Manufact... Failed Dissolution Specifications: Glipizide 2.5 mg ER Tablets exceeded dissolution specificati... Class II Actavis Inc
Jun 27, 2016 buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 t... Failed Dissolution Specifications Class III Sun Pharmaceutical Industries, Inc.
Jun 22, 2016 Alprazolam Extended-release Tablets, USP, 1 mg, 60-count bottle, Rx Only, Ma... Failed Dissolution Specifications Class II Mylan Pharmaceuticals Inc.
May 23, 2016 Nitrofurantoin Oral Suspension, USP, 25 mg/5 mL, FOR ORAL USE ONLY, URINARY T... Failed Dissolution Specifications Class II Nostrum Laboratories, Inc.
Mar 31, 2016 Intermezzo (zolpidem tartrate) sublingual tablet 1.75 mg, CIV, 30 Ct Cartons,... Failed Dissolution Specifications Class III Purdue Pharma L.P.
Feb 12, 2016 Paliperidone Extended-release Tablets, 1.5 mg, 30 count bottles, Rx only, Myl... Failed Dissolution Specifications; three month stability time point. Class II Mylan Pharmaceuticals Inc.
Jan 26, 2016 Duloxetine Delayed-Release Capsules, USP, 30 mg, 30-count bottles, Rx only, M... Failed Dissolution Specification: Out of specification dissolution results when testing product s... Class III Apotex Scientific, Inc
Jan 26, 2016 Duloxetine Delayed-Release Capsules, USP, 20 mg, 60-count bottles, Rx only, M... Failed Dissolution Specification: Out of specification dissolution results when testing product s... Class III Apotex Scientific, Inc
Jan 26, 2016 Duloxetine Delayed-Release Capsules, USP, 60 mg, 30-count bottles, Rx only, M... Failed Dissolution Specification: Out of specification dissolution results when testing product s... Class III Apotex Scientific, Inc
Jan 18, 2016 Levofloxacin Tablets USP, 500 mg, packaged in 100-count (10 x 10) blister car... Failed Dissolution Specifications: Unexplained low out of specification results for dissolution. Class II Amerisource Health Services
Dec 21, 2015 Capecitabine tablets USP 500 mg, Cytotoxic Agent, Rx Only, 120 tablets per bo... Failed Dissolution Specifications: low test results at the 18 month time-point Class II Teva North America
Dec 2, 2015 Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, pac... Failed Dissolution Specification Class III Pfizer Inc.
Sep 25, 2015 Metformin Hydrochloride Extended-Release Tablets, 1000 mg, 60-count bottle, R... Failed Dissolution Specifications: Low Out-of-Specification results for the 8 hour timepoint. Class II Actavis Laboratories, FL, Inc.
Sep 4, 2015 Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distr... Failed Dissolution Specifications: Failed 24 month dissolution testing. Class II Valeant Pharmaceuticals North America LLC
Aug 3, 2015 Rivastigmine Tartrate Capsules, USP 1.5 mg, 60 count bottle, Rx Only, Mfd. By... Failed Dissolution Specifications Class II Dr. Reddy's Laboratories, Inc.
Jul 29, 2015 Lisinopril Tablets, USP, 40 mg, a) 45-count bottle (NDC 0603-4214-60), b) 500... Failed Dissolution Specifications Class II Vintage Pharmaceuticals LLC dba Qualitest Pharm...
Jul 28, 2015 Dexmethylphenidate HCl Extended-Release, Capsules, 10mg, Rx only, 100 Capsule... Failed Dissolution Specifications: Product is being recalled due to out of specification (above s... Class III Novartis Pharmaceuticals Corp.
Jul 24, 2015 Nisoldipine Extended Release Tablets, 17 mg, packaged as a) Sular (nisoldipi... Failed Dissolution Specifications Class III Shionogi Inc.
Jul 24, 2015 univasc (moexipril HCl) tablets, 7.5 mg, 100 Ct Bottle, Rx Only. Manufactured... Failed Dissolution Testing: Failed 24 month dissolution testing. Class II Ucb, Inc
Jul 21, 2015 Verapamil Hydrochloride Extended-Release tablets, USP, 240 mg, 500-count bott... Failed Dissolution Specification: One lot of product did not meet the first stage dissolution spe... Class III Apotex Inc.
Jul 17, 2015 buPROPion Hydrochloride Extended-¿release Tablets USP (SR), 200 mg, Twice-A-... Failed Dissolution Specification: During analysis of the 18 month long term stability testing, it... Class III Sun Pharma Global Fze
Jul 13, 2015 Intermezzo (zolpidem tartrate), sublingual tablet 3.5 mg, 1 tablet per pouch,... Failed dissolution specifications Class III Purdue Pharma L.P.
Jun 30, 2015 Panadol (acetaminophen) Extra Strength, 500 mg, a) 30 count (UPC 1-03-53100-9... Failed Dissolution Specifications Class III GlaxoSmithkline Consmer Healthcare
Jun 30, 2015 Capecitabine Tablets, USP, 500 mg, 120-count bottle, Rx only, Mylan Pharmaceu... Failed Dissolution Specifications: low out-of-specification (OOS) results for dissolution were ob... Class II Mylan Pharmaceuticals Inc
Jun 18, 2015 Disulfiram tablets, USP, 500 mg, 100-count bottles, Rx only, Manufactured for... Failed Dissolution Specifications: During routine stability testing at the 12 month time point, ... Class III Qualitest Pharmaceuticals
May 22, 2015 Divalproex Sodium Extended-Release Tablets, USP, (valproic acid activity), 25... Failed Dissolution Specifications; exceeded specification at the 9 hour time point Class II Dr. Reddy's Laboratories, Inc.
May 22, 2015 Divalproex Sodium Extended-Release Tablets, USP, 500 mg, 100 count bottles, R... Failed Dissolution Specifications; exceeded specification at the 9 hour time point Class II Dr. Reddy's Laboratories, Inc.
May 20, 2015 Mycophenolic Acid Delayed-release Tablets, 180 mg, 120-count bottle, Rx only,... Failed Dissolution Specifications: Low out of specification dissolution results. Class II Mylan Lab Inc
May 11, 2015 Zebeta¿ (bisoprolol fumarate), tablets, 10mg, 30-count bottle, Rx only, Manuf... Failed Dissolution Specifications: OOS result during stability testing Class II Teva Pharmaceuticals USA
Apr 21, 2015 NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS CAPSULES, 100 mg, 100 count bottle, ... Failed Dissolution Specification; 6 month time point Class II Alvogen, Inc
Apr 17, 2015 Nifedipine Extended-Release Tablets, USP, 90 mg, 100 Tablet Bottles, Rx Only.... Failed Dissolution Specifications: High out of specification dissolution result at 1 hour time po... Class II Valeant Pharmaceuticals North America LLC
Mar 17, 2015 SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP,200 mg/ 40 mg per 5mL,... Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. Class II Akorn, Inc.
Mar 17, 2015 SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP,200 mg/ 40 mg per 5mL,... Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. Class II Akorn, Inc.
Mar 17, 2015 SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP 800 mg/ 160 mg per 5mL... Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. Class II Akorn, Inc.
Mar 2, 2015 Lamivudine and Zidovudine Tablets USP 150mg/300mg 30 Unit Dose Blisters, Rx O... Failed dissolution specifications Class II American Health Packaging
Feb 10, 2015 Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg, 90-count bottles,... Failed Dissolution Specifications Class II Actavis Elizabeth LLC
Jan 21, 2015 Levetiracetam, extended release tablets, 750 mg, 60-count bottle, Rx only, Ma... Failed Dissolution Specifications: 6 month time point. Class II Sun Pharma Global Fze
Nov 19, 2014 Mercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters pe... Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratori... Class II American Health Packaging
Oct 22, 2014 Mercaptopurine Tablets, USP 50mg, a) 60-count bottle (NDC 49884-922-02), b) ... Failed Dissolution Specifications: Product found to be out of specification (OOS) during stabilit... Class II Prometheus Laboratories Inc.
Sep 26, 2014 Bystolic (nebivolol) tablets, 20 mg/tablet, packaged as 7 tablets/bottle/cart... Failed Dissolution Specification; at the 6-month stability time point Class II Forest Pharmaceuticals Inc

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.